Joint Formulary & PAD

Nintedanib - Idiopathic pulmonary fibrosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Capsules
Associated Icons :
BNF SPC
NHSE
NICE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Nintedanib
Indication :
Idiopathic pulmonary fibrosis
Group Name :
Keywords :
Brand Names Include :
Ofev
Important Information :
NHSE Specialist Commissioned Services only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Nintedanib is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Idiopathic pulmonary fibrosis.

Committee Recommendations (1)

28 Feb 24 - Not Set

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.